Skip to main content
Figure 2 | BMC Surgery

Figure 2

From: Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study

Figure 2

Correlations between studied variables and recurrent tumor size in all patients. (a) Pre-treatment serum AFP level (AFPT0) and recurrent tumor size (RTS) were significantly correlated (r = 0.329 P < 0.05). (b) Recurrent tumor size (TST0) and RTS were not correlated (r = 0.020, P > 0.05). (c) The 3-month post-treatment serum level (AFTT3) and recurrent tumor size were significantly correlated (r = 0.312, P < 0.05).

Back to article page